[1] Brown GD, Denning DW, Gow NA, et al. Hidden killers:human fungal infections[J]. Sci Transl Med, 2012,4(165):165rv113.
[2] Cooper MA, Fehniger TA, Caligiuri MA. The biology of human natural killer-cell subsets[J]. Trends Immunol,2001,22(11):633-640.
[3] Spits H, Artis D, Colonna M, et al. Innate lymphoid cells-a proposal for uniform nomenclature[J]. Nat Rev Immunol,2013,13(2):145-149.
[4] Orange JS, Ballas ZK. Natural killer cells in human health and disease[J]. Clin Immunol,2006,118(1):1-10.
[5] Vivier E, Tomasello E, Baratin M, et al. Functions of natural killer cells[J]. Nat Immunol. 2008,9(5):503-510.
[6] Li SS, Kyei SK, Timm-McCann M, et al. The NK receptor NKp30 mediates direct fungal recognition and killing and is diminished in NK cells from HIV-infected patients[J]. Cell Host Microbe,2013,14(4):387-397.
[7] Mueller-Leisse J, Brueggemann S, Bouzani M, et al. Polymorphonuclear neutrophils and granulocytic myeloid-derived suppressor cells inhibit natural killer cell activity toward Aspergillus fumigatus[J]. Med Mycol,2015,53(6):622-629.
[8] Vitenshtein A, Charpak-Amikam Y, Yamin R, et al. NK cell recognition of Candida glabrata through binding of NKp46 and NCR1 to fungal ligands Epa1, Epa6, and Epa7[J]. Cell Host Microbe, 2016,20(4):527-534.
[9] Ogbomo H, Mody CH. Granule-Dependent natural killer cell cytotoxicity to fungal pathogens[J]. Front Immunol,2017,7(1):692.
[10] Kyei SK, Ogbomo H, Li SS, et al. Mechanisms by which interleukin-12 corrects defective NK cell anticryptococcal activity in HIV-infected patients[J]. Mbio,2016,7(4):e00878-16.
[11] Kinjo Y, Takatsuka S, Kitano N, et al. Functions of CD1d-restricted invariant natural killer T cells in antimicrobial immunity and potential applications for infection control[J]. Front Immunol,2018,9(1):1266.
[12] Bar E, Whitney PG, Moor K, et al. IL-17 Regulates systemic fungal immunity by controlling the functional competence of NK cells[J]. Immunity. 2014,40(1):117-127.
[13] Mah AY, Cooper MA. Metabolic regulation of natural killer cell IFN-gamma production[J]. Crit Rev Immunol,2016,36(2):131-147.
[14] Bouzani M, Ok M, McCormick A, et al. Human NK cells display important antifungal activity against Aspergillus fumigatus, which is directly mediated by IFN-gamma release[J]. J Immunol,2011,187(3):1369-1376.
[15] El-Khoury M, Ligot R, Mahoney S, et al. The in vitro effects of interferon-gamma, alone or in combination with amphotericin B, tested against the pathogenic fungi Candida albicans and Aspergillus fumigatus[J]. BMC Res Notes,2017;10(1):364.
[16] Homey B, Muller A, Zlotnik A. Chemokines:agents for the immunotherapy of cancer[J]? Nat Rev Immunol,2002,2(3):175-184.
[17] Voigt J, Hunniger K, Bouzani M, et al. Human natural killer cells acting as phagocytes against Candida albicans and mounting an inflammatory response that modulates neutrophil antifungal activity[J]. J Infect Dis,2014,209(4):616-626.
[18] Robinet P, Baychelier F, Fontaine T, et al. A polysaccharide virulence factor of a human fungal pathogen induces neutrophil apoptosis via NK cells[J]. J Immunol,2014,192(11):5332-5342.
[19] Schneider A, Blatzer M, Posch W, et al. Aspergillus fumigatus responds to natural killer (NK) cells with upregulation of stress related genes and inhibits the immunoregulatory function of NK cells[J]. Oncotarget,2016,7(44):71062-71071.
[20] Salazar F, Brown GD. Antifungal innate immunity:a perspective from the last 10 years[J]. J Innate Immun,2018,10(5-6):373-397.
[21] Lamoth F, Juvvadi PR, Steinbach WJ. Heat shock protein 90(Hsp90):A novel antifungal target against Aspergillus fumigatus[J]. Crit Rev Microbiol,2016,42(2):310-321.
[22] Blatzer M, Binder U, Haas H. The metalloreductase FreB is involved in adaptation of Aspergillus fumigatus to iron starvation[J]. Fungal Genet Biol,2011,48(11):1027-1033.
[23] Algarra I, Ortega E, Serrano MJ, et al. Suppression of splenic macrophage Candida albicans phagocytosis following in vivo depletion of natural killer cells in immunocompetent BALB/c mice and T-cell-deficient nude mice[J]. FEMS Immunol Med Microbiol,2002,33(3):159-163.
[24] Mehrad B, Park S, Hughes MA, et al. Early NK cell-derived interferon-gamma is essential to host defense in neutropenic invasive aspergillosis[J]. J Immunol,2009,182(7):4306-4312.
[25] Lipscomb MF, Alvarellos T, Toews GB, et al. Role of Natural-Killer-Cells in resistance to Cryptococcus neoformans infections in mice[J]. Am J Pathol,1987,128(2):354-361.
[26] Tewari RP, Von Behren LA. Immune responses in histoplasmosis, a prototype of respiratory mycoses[J]. Indian J Chest Dis Allied Sci, 2000,42(4):265-269.
[27] Hidore MR, Murphy JW. Natural cellular-resistance of Beige mice against Cryptococcus-neoformans[J]. J Immunol, 1986,137(11):3624-3631.
[28] Stuehler C, Kuenzli E, Jaeger VK, et al. Immune reconstitution after allogeneic hematopoietic stem cell transplantation and association with occurrence and outcome of invasive aspergillosis[J]. J Infect Dis,2015,212(6):959-967.
[29] Fernandez-Ruiz M, Lopez-Medrano F, San Juan R, et al. Low natural killer cell counts and onset of invasive fungal disease after solid organ transplantation[J]. J Infect Dis,2016,213(5):873-874.
[30] Chiu SJ, Tsao CH, Chen LC, et al. Chronic mucocutaneous candidiasis in a 6-year-old boy[J]. J Microbiol Immunol Infect,2004,37(3):196-199.
[31] Green MRJ, Kennell ASM, Larche MJ, et al. Natural killer cell activity in families of patients with systemic lupus erythematosus:demonstration of a killing defect in patients[J]. Clin Exp Immunol, 2005,141(1):165-173.
[32] Ruggeri L, Mancusi A, Capanni M, et al. Donor natural killer cell allorecognition of missing self in haplo-identical haematopoietic transplantation for acute myeloid leukaemia:challenging its predictive value[J]. Bone Marrow Transplant,2007,39(1):S32-S32.